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Testicular teratomas are thought to arise from the proliferation of primary 
germ cells (1).  Though  almost unknown  in most mice, these tumors occur in 
1%  of newborn strain  129  males,  apparently due  to multiple genetic factors 
in  this  inbred strain  (1).  Strain  129 spontaneous teratomas usually contain a 
bizarre  collection  of  differentiated  tissues,  and  differentiated  cells  persist 
indefinitely  in  most  transplantable  teratomas  ('2).  These  differentiated  cells 
appear  to  derive from undifferentiated pluripotent  stem cells or  "embryonal 
carcinoma"  (3).  Teratoma lines  adapted  to  culture  appear  to  remain undif- 
ferentiated.  However,  even after extended  periods  in  culture,  clones  of tera- 
toma were found to differentiate when reimplanted in  mice (4-7).  The range 
of teratoma differentiation in vivo is similar to that of normal embryos grafted 
to adults (8, 9). In particular both may produce "embryoid bodies," structures 
which  morphologically  and  histologically  resemble  early  gestation  embryos 
(10,  11).  Teratoma cells  then  would  seem an  excellent  starting  point  for  an 
investigation of antigens common to tumors and normal embryos. 
One of us reported previously that a rabbit antiserum to strain 129/J mouse 
teratoma 402AX reacts specifically with SV-40 transformed 3T3 cells and early 
mouse  embryos  (12).  Only  cells  of  the  embryonic portion  of  the  conceptus, 
those cells which would later express H-2 antigens, reacted with the antiserum, 
suggesting that perhaps the teratoma antigens are precursors to H-2 in normal 
development.  Antigens  common  to  early  embryos  and  virus-transformed 
cells have been reported  in  hamsters  (13,  14)  and  mouse  antimouse  embryo 
sera also define antigens common to a  range of murine tumor cells (15,  16). 
This report  concerns  our  efforts to determine  the  antitumor reactivities of 
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rabbit  anti-teratoma  serum,  and  the relationship of  these  antigens  to  11-2  on 
tumor  cells.  A  second  report  will  deal  with  teratoma  antigens  on  developing 
mouse embryos. 1 
Materials and Methods 
Tissue Culture--All tissue culture media were obtained from Grand Island Biological Co., 
Grand  Island,  New  York.  (Gibco).  Media  were  routinely  supplemented  with  Gibco  1% 
antibiotic/antimycotic mixture. 
Cells.-- 
Teratoma 402AX:  Teratoma 402AX, originally an embryoid body-rich ascite tumor, was 
obtained from Dr. Leroy Stevens (2) 8 yr ago and is passaged in our laboratory in male 129/J 
mice. The tumor grows rapidly and must be transplanted every 12-14 days.  Currently the 
ascites consists almost exclusively of single cells although foating masses are  occasionally 
observed. True  embyroid  bodies are not seen.  When cells are injected subcutaneously the 
resultant tumor consists primarily of small undifferentiated stem cells,  epithelial tissue re- 
sembling chorionic epithelium, and rhabdomyoblasts, precursors of striated muscle. Cartilage, 
originally present in solid teratoma 402 AX (2), is not observed. When not in use for prolonged 
periods,  the  teratoma  cells were  stored  in  ascites fluid  containing  10%  dimethylsulfoxide 
under liquid nitrogen. Thawed cells are more than 90% viable (by dye exclusion), and the 
growth  of  tumors  from  frozen  cells  occurs  without  a  detectable  lag. 
A subline of teratoma 402AX was adapted to culture by Dr. Ed McGuire 3 yr ago and is 
maintained in modified Eagle's medium supplemented with 5% calf and 5% fetal calf serum. 
Like the ascites tumor, the cultured line consists almost entirely of single cells some of which 
are epithelial in appearance. Aggregates of live ceils are observed to lift off the plate in heavy 
cultures, but these are  not embryoid  bodies. The cells were cloned twice without a  feeder 
layer before the onset of these studies. The cultured cells used in this work had been adapted 
to growth in 20 #g/ml 8-azaguanine for another purpose. Two other lines of cultured teratoma, 
adapted to culture independently within the past year and not grown in 8-azaguanine, react 
with the antisera in a  manner indistinguishable from the original subculture. "Teratoma A" 
refers to the ascites tumor and "teratoma C" to the cultured subline. 
Cultured cell lines:  BALB/c 3T3, SV-40 transformed BALB/c 3T3  (SV-3T3) ~,  BALB/c 
3T12,  and polyoma transformed BALB/c 3T3 cells were obtained from  Dr.  Stephen Roth 
and are maintained in Dulbecco's medium with 10% fetal calf serum. Flat revertants of SV- 
C  3T3  (10A-7-4)  were isolated by Dr.  H.  S.  Smith (17)  and given to us by Dr. Roth. These 
cells are characterized by slow growth in factor-free medium and cease to divide at confluence, 
but express T  antigen and yield infectious SV-40 virus on fusion with permissive cells.  The 
flat revertants (FR-SV-3T3) are maintained in Dulbecco's medium with 10% fetal calf serum. 
LM-Tk--clone  1D  (C1 1D), a  thymidine kinase negative subline of the C3H  "L" cell,  was 
isolated by Dubbs and Kitt (18), and given to us by Dr. H. G. Coon. C1 1D is maintained in 
Eagle's minimal essential medium with 5% fetal calf serum. 
Embryonicfibroblasts:  Primary fibroblasts were obtained by trypsinizing eviscerated  17- 
Gooding, L. R., Y.-C. Hsu, and M. Edidin. Teratoma cell-surface antigens expressed by 
early mouse embryos. Manuscript in preparation. 
2 Abbreviations used in this paper: CI 1D, Clone 1D; FL-GaM, fluorescein-conjugated goat 
anfimouse IgG; FR-SV-3T3,  flat revertants of SV-40 transformed BALB/c 3T3 cells; HH5, 
0.01  M  Hepes-buffered Hanks' solution (pH 7.3)  containing 5c'/c fetal calf serum; NRS, nor- 
mal rabbit serum;  Py-3T3,  polyoma virus transformed BALB/c 3T3  cells;  SV-3T3,  SV-40 
transformed  BALB/c  3T3  cells;  TMR-GaR,  tetramethylrhodamine-conjugated goat  anti- 
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20  day mouse embryos (19) and maintained in culture with Eagle's minimal essential me- 
dium supplemented with 20% fetal calf serum. 
Transplantable  tumors:  Adenocarcinoma  BW 10232 (C57BL/6J), melanoma  B16 (C57BL/ 
6J), and lymphatic leukemia BW 5147 (AKR/J) were obtained directly from Jackson Lab- 
oratories, Bar Harbor, Maine, and were not passaged by us. Hepatoma BW 7756 (C57L/J), 
also from Jackson Laboratories, was passaged in the laboratory of Dr.  G. M. Williams and 
generously supplied to us by him. Mastocytoma P815,  a DBA/2 ascites tumor, was obtained 
from Dr.  Christopher Henney. Two  methylcholanthrene-induced C57BI/6J  flbrosarcomas 
were obtained from Dr. Leon Parks; they were at passage 6 and 7, respectively, at the time of 
assay. 
Mice.--129/J,  B10.Br/SgSn, B10.A/SgSn, C57BL/10SgSn, and C3H/HeJ mice were pur- 
chased from Jackson Laboratories. Pregnant CF1 females were given to us by Dr. Y.-C.  Hsu. 
Antisera.--Anti-teratoma  serum was produced by injection of 2 X  l0 T teratoma C  cells 
suspended in 1.8 )<  l0 s BCG (Research Foundation, Chicago,  Ill.)  into  multiple  intrader- 
mal sites on the fanks of New Zealand white rabbits.  Rabbits were boosted with 2.5  )<  107 
live teratoma C intravenously and bled 7-9 days later. 
Anti-teratoma serum was absorbed with 129/J male mesenteric lymph node, spleen, thy- 
mus, and kidney cells obtained by gentle teasing and pressing tissues through a  200-mesh 
wire screen. 0.7  ml of twice washed, packed cells were mixed with 2 ml of antiserum. After 
3-5 h on ice, the cells were removed by centrifugation. After three such absorptions the anti- 
serum did not react by immunofluorescence  with fresh samples of the cells used for absorption. 
Normal rabbit serum was obtained  prior  to  immunization  with  teratoma.  Anfimouse 
cell reactivity was removed by absorption with 129/J cells as above. 
Rabbit anti-teratoma serum was tested for reactivity against a variety of murine viruses by 
Microbiological Associates, Bethesda, Md.  The serum did not react with reovirus  type-3, 
sendal, ectromelia, mouse adenovirus, mouse  hepatitis  virus,  Theiler's  mouse  encephalo- 
myelitis (GD VII), minute virus of mice, newborn mouse pneumonitis (K virus), pneumonia 
virus of mice, or lymphocytic choriomeningitis virus.  It did, however, significantly inhibit 
polyoma virus induced agglutination of guinea pig red blood cells, and our own tests confirm 
this finding (Table I). 
We have further observed that extensive absorption of the anti-teratoma C  serum with 
TABLE  I 
Reaction  of Anti-Teratoma  Serum  with  Polyoma  Virus  and  a  Polyoma-Associated  Antigen 
Anti-teratoma serum absorbed  with:  HAI titer 
%staining cells* 
Ter A  Ter C  Py-3T3 
--  1/640  99  100  90 
Teratoma A  1/640  3  82  92 
Teratoma A +  Py virus  <1/40  --  86  85 
Teratoma A +  gp RBC's  1/640  --  --  -- 
Teratoma C  1/640  9  5  4 
NRS  <1/10  1  2  1 
Hemagglutination inhibition (HAI)  was performed by incubation of 8  HAU of purified 
polyoma virus (the kind gift of Dr. Carlo Croce)  with serial dilutions of antiserum in a final 
volume of 0.1  ml. After 18 h  at 4°C,  0.05  ml of guinea pig red blood cells at  10S/ml  were 
added and samples incubated at 37°C for 15 rain and then at 4°C for 2 h. 
* Cell surface immunofluorescence was performed as described in Materials and Methods 
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teratoma A cells fails to remove all antibody reacting by immunofluorescence with live tera- 
toma C  (Table I), indicating the presence of an antigen expressed by the cultured subline but 
not in detectable amounts by the parent ascites tumor.  Polyoma 3T3 cells also react with 
teratoma A absorbed serum (Table I), suggesting that perhaps the serum is reacting with a 
polyoma-specific  cell  surface  antigen.  The  two  activities,  antipolyoma  virus  and  anticell 
surface, are distinct from one another since appropriate absorption of the antiserum removes 
one  without  affecting  the  other  (Table  I). 
It is uncertain why rabbits injected with live teratoma C  produce antibody to polyoma 
virus. It is probable from the results in Table I  that teratoma C is transformed by the virus, 
but the cells are not producing virus in detectable amounts. Attempts to rescue polyoma virus 
from teratoma C  by sendal virus fusion with both mouse and rabbit embryonic fibroblasts 
have been unsuccessful. Perhaps most surprising is the finding that the cultured cells express 
this polyoma-associated cell surface antigen, while the ascites tumor cells from which they 
were derived do not. Two separate lines of teratoma 402AX have subsequently been adapted 
to  culture and  both express  the polyoma antigen. 
None of the tumor and cultured ceils reported in this study react with teratoma A  ab- 
sorbed antiserum  by  immunofluorescence. Tumor  cells,  eliminated  from  consideration be- 
cause they did react with teratoma A absorbed serum were solid Sarcoma I, ascites Sarcoma I, 
and melanoma HP, all from Jackson Laboratories. 
Anti-//-g  k alloantiserum was prepared by intraperitoneal injection of C57BL/6 X  DBA/2 
F1 mice with B10.Br lymphocytes. Serum was made//-g-specific by three serial absorbtions 
with B10.D2 lymph node and spleen ceils performed as described above. 
Monospecific anti-//-g.ll  and H-g.3g  were obtained from  the Transplantation and Im- 
munology Branch, NIAID.  Rabbit anti-T-cell antigen was kindly provided by Drs.  Gerry 
Cole and  Christopher Henney.  This antiserum, prepared by injection of mouse brain and 
absorbed on mouse red cells, reacts specifically with thymus-derived lymphocytes (20). 
Fluorescent Reagents.--Fluorescein-conjugated  goat antimouse IgG  (FL-GaM)  and tetra- 
methylrhodamine-conjugated goat antirabbit IgG  (Fc)  (TMR-GaR)  were prepared as de- 
scribed previously (21). 
Indirect  Immunofluorescent Staining  of Cells.--Unless  otherwise indicated, cultured  cells 
were  harvested with 2.5%  heat-inactivated chicken serum, 0.2%  trypsin, 0.002%  purified 
collagenase  (Worthington Biochemical Corp.,  Freehold,  N.  J.)  in Moscona's solution  (22). 
5  X  105 cells, washed twice in 0.01  M  Hepes buffered Hank's solution (pH 7.3)  containing 
5% fetal calf serum  (HHS),  were incubated with 0.05  ml of antiserum on ice  for  15 min. 
Antiserum was  diluted  in  HH5  containing 2.5  mM  dinitrophenol  (DNP-HH5)  to  inhibit 
pinocytosis. The cells were washed twice with DNP-HH5 to remove excess serum and stained 
with 0.05 ml of the fluorescent conjugate for 15 min on ice.  Excess conjugate and  DNP  were 
removed by three washes with HH5.  All samples were encoded before observation and read 
as unknowns. 
Fluorescence microscopy was performed as described previously (21).  Counts were done on 
100-200 cells to determine the percentage of stained ceils.  Pictures were taken using a Leica 
camera and GAF-500 color film. Film was processed with a GAF developing kit to an ASA of 
i,000. 
Capping.--Cl  1D cells were stained as described above except that DNP was omitted. After 
final washes, the cells were incubated at 37°C  for 90 min for maximal capping of the fluores- 
cent label. At the optimal serum concentration 60-90% of cells were capped  by anti-H-g  k 
and approximately the same percentage with anti-teratoma. 
RESULTS 
Reactivity  of  the  Anti-Teratoma  Serum  with  Normal  Mouse  Tissues--The 
rabbit anti-teratoma  serum  displayed high titres of reactivity with  the immu- LINDA  R.  GOODING  AND  ~fICHAEL  EDIDIN  65 
nizing cells (Fig.  1).  Surprisingly little of this activity is directed against anti- 
gens common to normal  mouse  cells,  since as shown in Fig.  1 the  antiserum 
reacts  poorly with  129/J  lymph  node  cells.  A  single  absorbtion  with  lymph 
node cells removes this activity while having no effect on the staining of tera- 
toma itself.  To  ensure  removal  of this  activity,  antiserum  absorbed  on  cells 
from a collection of normal 129/J tissues (see Materials and Methods) was used 
for all experiments described here. 
The reactivity of the absorbed anti-teratoma serum with cells from a variety 
of adult mouse tissues is shown in Table II. With the exception of ovary, none 
of the normal cells, either teased apart or dissociated with trypsin, reacted with 
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FIG. 1. Reaction of crude and absorbed rabbit anti-teratoma serum with the teratoma and 
lymph node cells.  Cells were incubated with serial dilutions of anti-teratoma serum and a con- 
stant amount of TMR-GaR as described in Materials and Methods.  0,129/J  lymph node 
cells with  unabsorbed  anti-teratoma.  ×,  129/J  lymph node cells with  lymph node cell-ab- 
sorbed anti-teratoma  (1/~ ml undiluted  serum:packed  cells of one mesenteric lymph node). 
O,  Teratoma  C with  unabsorbed  or lymph node  cell-absorbed anti-teratoma.  A,  129/J 
lymph node cells with normal rabbit serum. A, Teratoma C with normal rabbit serum. 
the  antiserum.  If any antigens  which react  with  the  anti-teratoma  serum  are 
present  on  these  normal  cells,  they are  expressed  at  levels  too low  to be  de- 
tected by our assay system. 
The  fluorescent  stain  on  dissociated  ovary cells  could  not  be  removed by 
further  absorption  of  the  anti-teratoma  serum  with  normal  cells  other  than 
ovary itself. Staining of frozen sections of ovary with the anti-teratoma serum 
revealed  bright  cytoplasmic fluorescence on cells  of the  theca interna  and lu- 
teinized stromal cells. 
Teratoma Antigens Expressed by Cultured Mouse Fibroblast Cells.--As shown 
in Fig.  2  a,  the  anti-teratoma  serum reacts  strongly with  living  SV-40 trans- 
formed 3T3  cells  and  with  3T12  cells.  It reacted  weakly with  3T3  cells  and 
SV-40 transformants  which have reverted  to normal growth regulation.  How- 
ever,  if  these  "normal"  cells  are  treated  briefly  with  crude  trypsin  before 66  TERATOMA  ANTIGENS 
TABLE II 
Staining of Cells from Normal 129/J Tissues by Anti-Teratoma Serum 
Cells  NRS* 
Anti-teratoma* 
Teased  Trypsin 
Lymph node  4  0  0 
Spleen  7  1  1 
Thymus  3  0  0 
Kidney  4  6  10 
Intestine  14  12  -- 
Brain  3  6  0 
Liver  10  6  0 
Peritoneal exudate cells  2  1  6 
Testis  4  7  1 
Ovary  4  73  61 
129/J organs were removed and dissociated by gentle teasing. A portion of each was disso- 
ciated  with 0.25%  Difco trypsin  in phosphate  buffered saline at room  temperature.  Peri- 
toneal exudate cells were washed from the peritoneal cavity with  HH1 and a portion  treated 
with trypsin.  NRS controls were done on trypsinized  cells. 
* Sera at 1:10 dilution;  results presented as percentage stained cells. 
staining (Fig. 2 b), their reaction with antiteratoma serum is greatly increased. 
Trypsin  treatment  has  a  slight  effect  on staining  of the  transformed  cells  as 
well,  but this may be due simply to rounding of the cells,  thus increasing  the 
apparent brightness  of the fluorescent stain.  Intact primary and early passage 
mouse embryonic fibroblasts do not react significantly with the anti-teratoma 
serum,  even  after  treatment  with  trypsin  (Table  III). 
Co-capping  of the  Teratoma Antigens  and  H-2 on  C1 1D.--A  subline  of the 
C3H L-cell, C1  1D,  also expresses teratoma antigens,  most of which are  avail- 
able for fluorescent staining  only after  the cells  are treated  with  trypsin  (Fig. 
3).  Trypsinized  CI  1D  cells  were  stained  for the  teratoma  antigens  and  then 
incubated  at  37°C.  Under  these  conditions,  between  60  and  90%  of the  cells 
"cap,"  that  is,  the  fluorescent  antigen-antibody  complexes  migrate  to  one 
pole of the cell  (Fig. 4  a).  These cells were then  incubated with  a  mouse  allo- 
antiserum  which  reacts  with  several  H-2  ~ specificities  and  FL-GaM  in  ice  so 
that no further capping could occur. The co-incidence of rhodamine and fluores- 
cein stain on the capped cells (Fig. 4 a  and b) indicates that both the H-2 anti- 
gens and the teratoma  antigens  had been capped by the antiteratoma  serum. 
The same result  is  observed  when  the H-2  antigens  are  capped  and  the  cells 
stained  in  the  cold with  anti-teratoma  (not  shown). 
H-gD and H-2K molecules cap independently of one another in lymphocyte 
membranes (23), and the same is true of H-2 antigens on Cl 1D (M. Edidin and 
A.  Weiss,  unpublished).  Therefore,  monospecific  anti-H-2  sera  were  used  to 
determine  which of the  alloantigens  was responsible  for co-capping with  tera- 
toma  antigens.  When  H-2D molecules  are  capped  and  the  cells  then  stained LINDA  R.  G00DING  AND  MICHAEL  EDIDIN  67 
with anti-teratoma, again capping of the teratoma antigens is observed (Fig. 
4 c and d).  Capping of the H-2K molecules (with anti-H-2.32)  also caps the 
teratoma antigens (not shown). In both cases capping of the teratoma antigen 
was incomplete. 
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FIG. 2. Reaction of anfi-teratoma serum with transformed and normal fibroblast cell lines. 
(a)  Cells, plated onto cover slips 48 h  before assay, were stained in situ with serial dilutions 
of anti-teratoma serum and a constant amount of TMR-GaR. All samples were subconfluent. 
(b)  Plated cells were treated with 0.25% Difco trypsin in phosphate-buffered saline 1 min on 
ice before staining. Treated  cells remained attached  to cover slips. 
TABLE  III 
Reaction of A nti-Teratoma  Serum with Trypsinized  Embryonic  Fibroblast Cell Cultures 
Cells  Passage 
% stained cells 
NRS  Anti-teratoma 
CF1  0  8  5 
B10.Br  3  5  4 
C57BL/10  4  t  12 
B10.A  5  2  17 
3T3  --  4  87 
NRS and anti-teratoma sera at 1:40 dilution. 68  TERATOMA  ANTIGENS 
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FIG. 3. Reaction of anti-teratoma serum with CI 1D cells. Cells were stained on cover  slips 
as described for Fig. 2. 
To be certain  that  the  observed co-capping of H-3 and  teratoma antigens 
was in no way inherent to the procedure employed, the same sera and fluores- 
cent reagents were used to look at capping with another fibroblast cell marker. 
Fibroblasts express 0-antigen (24), and a heterologous rabbit anti-T-cell serum 
reacts with C1 ID cells. In Fig. 4 e and/, C1 1D cells were capped with the poly- 
specific anti-H-2  k and then stained with the rabbit anti-T cell.  No co-capping 
was observed. The reciprocal experiment,  capping of the  T-cell antigens  and 
then staining with anti-H-2  k also failed to produce co-capping (not shown). 
Controls, shown in Table IV, were performed to ensure that the co-capping 
of H-2 and the teratoma antigens on C1 1D was not due to unexpected interac- 
tions among the reagents employed. The fluorescent reagents react only with 
the specified antiserum and not with the cells themselves or with  each other. 
The anti-teratoma does not react with H-3  k lymphocytes, nor does it bind anti- 
H-2  k antibody.  The  anti-H-2  k does not  bind  to  teratoma  cells  and  does not 
react  with  the  anti-teratoma  antibody. 
Teratoma  Antigens Expressed by  Transplantable Murine  Tumor Cells.--The 
anti-teratoma serum reacts with  living cells from a  variety of transplantable 
mouse tumors  (Table V).  Staining  of these  cells is  little  affected by trypsin. 
One tumor tested,  a  lymphatic leukemia, reacted poorly with  the antiserum, 
and because of the limitations of the assay system, expression of antigens on 
these  cells  is  questionable.  Two  tumors,  both  early  passage  methylcholan- 
threne-induced  fibrosarcomas, clearly did not  react  with  the  antiserum  even 
after treatment  of the  cells with  trypsin. 
It was of interest  to determine whether  the various cells which react with 
the antiserum are expressing the same antigens, particularly the antigens which 
co-cap with H-2 on C1 1D cells. This question was approached by the absorption 
studies shown in Table VI. Absorption of the antiserum with any reactive cell 
tested completely removes antibody binding to C1 1D, melanoma and SV-3T3. 
This indicates  that  of the  cells tested,  all  those reacting  with  the  antiserum FIG. 4. Capping of surface antigens on C1 1D. C1 1D cells were capped and restained on ice 
as described in Materials and Methods. (a) and (b) TMR and FL fluorescence,  respectively, 
of cells capped with rabbit anti-teratoma (1:40)  and TMR-GaR then restained on ice with 
mouse anti-H-2  k (1:4) and FL-GaM. (c) and (d) FL and TMR fluorescence,  respectively of 
cells capped with mouse anti-H-2.11  (undiluted)  and FL-GaM, then restained on ice with 
rabbit anti-teratoma (1:40)  and TMR-GaR.  (e) and (f) FL and TMR fluorescence,  respec- 
tively, of cells capped with mouse anti-H-2  k  (1:40)  and FL-GaM then restained on ice with 
rabbit  antimouse T-cell  antigen  (1:40)  and  TMR-GaR. 
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express  a  common  antigen  or  antigens,  and  furthermore  these  antigens  are 
cross-reactive with those expressed on CI 1D cells. Also, since absorption of the 
serum with  Cl  1D removes all staining on melanoma and SV-3T3,  these cells 
are  expressing only teratoma-defined antigens  found  on  C1  1D. 
TABLE  IV 
Controls for  Reagent  Specificity 
Sera  % stained 
Cells 
First  Second  Third  Fourth  cells 
CI 1D 
C3H lymphocytes 
Teratoma A 
Anti-H-2  k (abs.)*  FL-GaM  --  --  2 
Anti-teratoma (abs):~  TMR-GaR  --  --  t 
Anti-H-2  k  TMR-GaR  --  --  0 
Anti-teratoma  FL-GaM  --  --  2 
Anti-H-2  k  FL-GaM  TMR-GaR  --  93  (FL) 
0  (TMR) 
Antiteratoma  TMR-GaR  FL-GaM  --  92  (TMR) 
1 (FL) 
Anti-teratoma (abs) :~  TMR-GaR  --  --  0 
Anti-H-2  k (abs)*  FL-GaM  --  --  7 
Anti-teratoma  TMR-GaR  --  --  0 
Anti-H-2  k  FL-GaM  Anti-teratoma  TMR-GaR  82  (FL) 
0 (TMR) 
Anti-teratoma (abs) 1:  TMR-GaR  --  --  0 
Anti-H-2 k (abs)*  FL-GaM  --  --  3 
Anti-H-2/~  FL-GaM  --  --  0 
Anti-teratoma  TMR-GaR  Anti-H-2  k  FL-GaM  95  (TMR) 
0  (FL) 
C3H lymphocytes were prepared  from mesenteric lymph node by pressing through a fine mesh wire screen. 
All reagents were at the same concentrations used in Fig. 4. Controls: (*), anti-H-2  k serum absorbed on B10.Br 
(H-2  k) lymph node and spleen cells;  (:~), anti-teratoma serum absorbed on teratoma  C. 
TABLE  V 
Reaction  of Anti-Teratoma  Serum  with  Cells  of  Transplantable  Mouse  Tumors 
Cells 
%stain on trypsinized 
cells at 1:10  serum diln.  Fluorescence titer 
NRS  Anti-  Teased  Trypsin  teratoma 
Melanoma  B16  14  90  1:40  1:80 
Adenocarcinoma  BW10232  3  64  1  20  1  40 
Hepatoma  BW7756  4  91  1:80  1 : 160 
Mastocytoma  P815  0  72  1:40  1:40 
Lymphatic  leukemia  BW5147  2  22  --  -- 
Fibrosarcoma  MC1  3  3  --  -- 
Fibrosarcoma  MC3  0  2  --  -- 
A  portion of each solid tumor  mass was dissociated by gentle teasing in HH5.  Another  por- 
tion was dissociated with 0.25~,  Difco trypsin in phosphate  buffered saline at room tempera- 
ture.  Mastocytoma  cells were  washed  twice in  HH5  and  a  portion  treated  with  trypsin  as 
above.  "Titer"  is defined as  the lowest concentration  of antiteratoma  where  more  than  50~v 
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TABLE  VI 
Absorbtion  o/  Anti-Teratoma  Serum  with  Tumor  Cdls 
Cells, stained with:  NRS 
Anti-teratoma  absorbed with: 
Adeno-  Melanoma  Hepatoma  TeratomaA  CI 1D  carcinoma 
C1 1D~  4*  82*  4  8  8  8  2 
Melanoma~  4  94  3  4  6  1  3 
SV-40-3T3~  2  91  3  3  l  3  1 
Hepatomall  0  82  6  90  81  77  7 
Teratoma A¶  0  83  1  84  82  64  36 
1 vol of anti-teratoma serum (absorbed  on normal tissues as described in Materials and 
Methods) at 1 : 5 was absorbed twice with 1 vol of trypsinized packed tumor cells for 3-5 h  on 
ice. Test cells were incubated with the lowest serum concentration giving about 100% stained 
cells with unabsorbed antiteratoma serum. All test cells were treated with trypsin prior  to 
staining. 
* Results  are  expressed  as  percent  stained  cells.  Serum  dilutions:  ($)  1:20;  (ID  1:40; 
(¶) 1:8o. 
Aside from this common antigenic activity, the absorption studies revealed 
other reactivities in the anti-teratoma serum. Absorption with C1  1D, adeno- 
carcinoma or melanoma, which removes the common antigens, has little effect 
on the staining  of hepatoma and teratoma itself. Absorption with hepatoma 
however removes most antibody reacting with the teratoma, indicating that a 
second activity is shared by teratoma and hepatoma but not by the other tumor 
cells tested. 
Because absorbtion of the antiserum which removes the common antigens 
does not affect staining  of the teratoma,  most of the very high  titer against 
teratoma cells must be due to the antigens shared by teratoma and hepatoma. 
It is probable that the serum reacts with a third antigen, one specific for tera- 
toma only, since in repeated experiments absorbtion with hepatoma did not 
remove all  antibody which  reacts  with  teratoma. 
The  antigen  or  antigens  responsible  for  the  verk  high  titer  of  the  anti- 
teratoma serum with teratoma itself appear to be secreted or shed by teratoma 
cells into their ascites fluid. Absorbtion of the antiserum with teratoma ascites 
fluid removes all reactivity when teratoma cells  are stained  at a  serum dilu- 
tion of 1 : 80, but extensive absorbtion with ascites fluid has no effect on staining 
at a dilution of 1:20 (Table VII). This result would indicate that absorbtion 
with ascites  fluid removes activity with  one antigen expressed by teratoma, 
probably the high-titered antigen shared by teratoma and hepatoma, but does 
not remove a second, lower titered, activity. Absorbtion with ascitic fluid has 
no effect on staining of CI 1D cells. 
Teratoma  Antigens  of Mouse Ovarian  Cells.--Absorbtion  studies  were  also 
used  to determine which  of the  antigens  reacting with  anti-teratoma  serum 
was responsible for staining of ovarian cells (Table VIII). Absorbtion of the 
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TABLE VII 
Teratoma  Cell Antigens  in  Teratoma Ascites  Fluid 
Cells, stained with:  Serum diln.  Anti-teratoma 
Ascites fluid:anti-teratoma  serum* 
2:1  20:1 
Teratoma A  1:80  83~  4  -- 
1:20  96  91  95 
C1 1D  1:20  85  --  91 
* Ascites fluid from 129/J  teratoma  carriers was spun at low speed to remove cells and 
then at 100,000 g for 60 rain to remove cell fragments and debris. Antiteratoma serum at 1  : 2 
was absorbed with an equal or 10-fold volume of clarified ascites fluid at room temperature 
1-2 h. Ascites fluid alone does not stain either teratoma A or C1 1D cells. 
:~ Results are expressed as percent stained cells. 
TABLE  VIII 
Teratoma Antigens in Normal Mouse Ovary 
Cells  stained with:  NRS  --  Ovary  C1 ID  Hepatoma 
Teratoma A*  1  85  13  84  38 
C1 1D$  2  62  9  2  8 
Ovary~t  0  66  21  65  ll 
Absorbtions were performed as described in Table VI. Ovaries from C3H females were 
used as absorbing and test ceils. Ovary cells were obtained by gentle  teasing in the presence 
of 0.25% Difco trypsin in phosphate-buffered saline. Results are expressed as percent cells 
stained Serum dilutions: (*) 1:80; (*) 1:20. 
suggesting that both common and teratoma/hepatoma antigens are expressed 
in the  ovary.  Cl  1D  absorbtion, which removes reactivity with the  common 
antigen only, has no effect on staining of ovarian cells while absorbtion with 
hepatoma,  which  removes  both  activities, removes  essentially all  antiovary 
reactivity. This indicates that, as was the case with the teratoma, most of the 
stain on ovarian cells is due to the  teratoma/hepatoma antigens. Staining of 
ovarian  sections  with  absorbed  antisera  (not  shown)  gave  results  identical 
to those obtained with membrane stain on live cells. 
Cellular Distribution  of the Common  Teratoma Antigens.--The  common tera- 
toma  antigens are  not confined to  the  plasma membrane. Fixed C1  1D  cells 
stain in the cytoplasm, and this fluorescence is removed by absorbtion of the 
antiserum with live C1  1D  (Fig. 5  a  and b).  Cytoplasmic staining is also ob- 
served in melanoma, SV-40-3T3, and 3T3 cells. In each case absorbtion of the 
antiserum with live C1  1D  removes the stain. 
At least a  portion of  the  cytoplasmic antigens are  soluble, not membrane 
bound, since absorbtion of the antiserum with a  100,000 g,  120 rain, supernate 
of lysed Cl  1D  cells abolish cytoplasmic staining (Table IX). This supernate 
also absorbs antibody which binds to live cells, indicating that the cytoplasmic 
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Fro.  5. Anti-teratoma serum staining of fixed  CI 1D.  Cells,  plated onto cover slips 48 h 
before staining, were air dried then fixed in acetone at --70°C. Fixed cells were incubated at 
room temperature with undiluted normal goat serum, rabbit antiserum, and TMR-GaR for 
10 min each with rinses in HH5 between each step. All sera were at 1:20 dilution. (a)  C1 1D 
plus anti-teratoma serum.  (b)  C1  1D with anti-teratoma serum absorbed  on live C1  1D  (see 
Table VI). 
TABLE IX 
IntraceUular Distribution of the  Common Teratoma Antigen 
Anti-teratoma serum absorbed with: 
% stained cells 
Live (surface)  Fixed (cytoplasmic) 
--  85  95 
Live C1 1D  2  5 
C1 1D supernate*  7  10 
Fixed C1 1D cells were prepared and stained as described in Fig. 5. Anti-teratoma serum 
was absorbed with live CI 1D as described in Table VI. Sera were used at 1:20 dilution. 
* CI 1D cells were lysed by gentle homogenization in a loose-fitting glass homogenizer and 
particulate debris removed by centrifugation at I00,000  g for 120 min. 1 vol of anti-teratoma 
serum at 1:2 was absorbed with 4 vol of this supernate overnight at 4°C. 
DISCUSSION 
Absorbtion  studies  of  anti-teratoma  serum  reveal  at  least  three  antigens. 
One  antigen  is  apparently  common  to  most  tumor  and  transformed  cells  in- 
vestigated  thus  far.  It  is  not  a  "universal"  tumor  antigen  since  two  tumors, 
both  early-passage  chemically induced  fibrosarcomas,  failed  to  react  with  the 
antiserum.  A  second antigen is expressed  only by the hepatoma  and  teratoma. 
The third  antigen,  inferred from the failure of hepatoma  absorbtion  to remove 
all  antibody  reacting  with  the  teratoma,  may  be  specific for  teratoma. 
Two  BALB/c  fibroblast  cell  lines,  3T3  and  FR-SV-3T3,  react  well  only 
after  treatment  with trypsin  while SV-3T3  and 3T12  cells react strongly with- 
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these cells is unclear. However, the results indicate that similar concentrations 
ofreactive antigens are present on both "normal" and transformed fibroblast 
lines  though  their  availability  to  antibody  varies.  This  situation  strongly 
parallels that observed for binding of concanavalin A  (Con A)  to normal and 
transformed fibroblasts (25). At 0°C, the temperature at which our incubations 
are  performed,  polyoma-transformed  3T3  cells  bind  three  times  as  much 
[3H]Con A as do 3T3 cells.  Trypsin treatment of 3T3 cells results in an almost 
threefold increase in binding at 0°C. 
While both transformed and normal mouse fibroblast cell lines express the 
common antigen  on  their  surface,  significant levels of the  antigen  were not 
detected on live primary and early-passage fibroblast cell cultures from several 
strains of mice. If these cells express the common antigen, it is at a level below 
the limit of sensitivity of our assay. Thus, expression of the antigen, in a quan- 
titative sense at least, is a property of fibroblast cell lines, and not of cultured 
fibroblasts per se. 
The common teratoma antigen  was  found to co-cap with  both  the H-2D 
and H-2K molecules on C1  1D  cells.  Although we will  refer to this antigen in 
the singular,  it is not known whether the same or two different antigens are 
involved in the co-capping. Capping behavior of membrane markers in other 
experiments has agreed well with biochemical association of molecules following 
their removal from the membrane. The two H-2 polypeptides, H-2D and H-2K, 
are readily separable  by specific immunoprecipitation following either deter- 
gent  (26)  or  papain  (27)  solubilization  and  do  not  co-cap on  lymphocytes 
(23). On the other hand, ~-2 microglobulin co-purifies with the human histo- 
compatibility antigens, HL-A  (28, 29), and co-caps with the HL-A antigens of 
lymphocytes (30). 
Recently Fujimoto and co-workers (31)  reported that  H-2  antigens  and a 
tumor-associated antigen co-purify on immunoabsorbtion of serum from lymph- 
oma bearing mice. This tumor antigen was also defined by a heterologous anti- 
serum, but nothing further is known about the tumor specificity of the anti- 
gens involved. 
Of the cells tested thus far, all  those which express the common teratoma 
antigen in the plasma membrane stain for the antigen in the cytoplasm as well. 
At least a portion of this cytoplasmic antigen in C1  1D is not associated with 
particulate fractions. A  similar  cellular distribution has been observed for a 
tumor-associated embryonic antigen.  Baldwin and his  co-workers found that 
an antigen defined by multiparous rat serum was localized both in the plasma 
membrane  and  cell  sap  of many  chemically-induced rat  tumors  (32).  ]~t  is 
possible  that  the  soluble,  cytoplasmic  antigen  is  not  associated  with  H-2. 
While preliminary results indicate that most of the common antigen in C1 1D 
cells is soluble, H-2 in cells is always membrane-bound (33). 
Of the normal tissues tested, only ovary contained the common tumor an- 
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known since the very bright staining due to the teratoma/hepatoma antigen 
on  ovarian  sections  effectively masks  the  presence  of  the  weaker  common 
antigen.  However,  since  the  common  antigen  is  expressed  by  unfertilized 
mouse ova,  1 it is possible that immature ova and germ cells in the ovary are 
also expressing the antigen. 
Of the three antigens thus far found to react with our rabbit anti-teratoma 
serum, the strongegt is the teratoma/hepatoma antigen. This antigen appears 
to be a secretory product of teratoma cells, and it is also expressed on the sur- 
face of parietal yolk sac cells. 1 The tissue distribution of this  antigen suggests 
it  might  be  a-fetoprotein,  a  fetal  serum  protein  found  associated  with  and 
presumably synthesized by parenchymal  cells  of fetal  liver  and  by parietal 
yolk sac (34). It is also secreted by many teratoma and hepatoma cells includ- 
ing hepatoma BW 7756 and several 129 teratomas (35). Although the homolo- 
gous antigen is  not immunogenic, a-fetoproteins from several species proved 
strong heteroantigens (36). Thus, if 402AX secretes a-fetoprotein, a rabbit anti- 
serum to the cells would certainly react with this antigen. 
In a recent paper, Artzt and her co-workers describe the reactivities of an 
anti-teratoma serum  prepared by injection of irradiated  cells  into syngeneic 
mice (37). Their teratoma F9, a subline of OTT-6050 (9), is composed entirely 
of embryonal carcinoma cells  which  have lost  the  ability  to differentiate in 
vivo. Anti-F9 serum reacts with other embryonal carcinoma lines, with early 
cleavage  embryos,  and  with  testicular  cells.  It  did  not  react  with  any of a 
variety of mouse tumor cells, while our rabbit anti-teratoma defines an antigen 
common to most  of our  tumor  test  cells.  Very similar  though  not  identical 
cells were used in the two studies, i.e., Artzt's 3T3 and SV-3T3 cells were de- 
rived from Swiss embryonic fibroblasts while ours were from BALB/c embry- 
onic fibroblasts. One possible explanation for this difference is  that  the com- 
mon antigen is not immunogenic in mice. A second possibility is that F9 does 
not express the common antigen. Teratoma 402AX differs from teratoma F9 
in at least one important regard; 402AX retains the ability to differentiate in 
vivo. Perhaps then the common antigen reflects a commitment before differen- 
tiation,  but  is  not  expressed on fully differentiated normal  tissues.  ~t  is  re- 
expressed by cultured cells concomitant with the requisite changes involved in 
establishment of a cell line and by tumor cells. 
SUMMARY 
Rabbit antisera to a mouse testicular teratoma, absorbed with normal mouse 
tissues,  react  by  immunofluorescence with  plasma  membrane  antigens  of  a 
variety of  transplantable  mouse  tumor  cells  and  transformed fibroblast  cell 
lines including Clone 1D, SV-40-3T3, and 3T12. Trypsin treatment of cells of 
"normal" lines,  3T3  and  FR-SV-3T3,  uncovers reactivity on  these  as  well. 
Early passage mouse embryo fibroblast cell cultures do not react even after 
trypsinization. By cross-absorbtion studies,  the anti-teratoma serum appears 76  TERATOMA  ANTIGENS 
to react  with  an  antigen  common  to most  tu~nor  cells investigated thus  far. 
When  this  antigen  on  Clone  1D  cells is "capped,"  H-2  antigens  collect with 
the  teratoma  antigens  in  the  cap  indicating  a  physical  association between 
the molecules.  Molecules specified by both  the  H-2D  and  H-2K  regions are 
bound  to  the  teratoma  antigens  in  the  Clone  1D  plasma  membrane.  This 
antigen is also found in soluble tumor cell fractions where it is believed to be 
free of H-2.  A  second  cell surface  antigen defined by  anti-teratoma serum  is 
expressed only by hepatoma and teratoma itself. This second antigen is appar- 
ently a  secretory product of teratoma cells. A  third surface antigen defined by 
anti-teratoma  serum  appears  to  be  specific for  the  teratoma. 
The authors wish to thank Dr. Ramesh Kamat for his comments on tumor histology and 
Ms. Avril McCheyne for able technical assistance. 
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